Leptomeningeal metastases represent a rare complication of systemic malignant disease.

In this setting, outcomes have historically been invariably poor.

These data demonstrate that specific subsets of patients may experience better than expected outcomes warranting aggressive intervention.

The addition of whole brain radiotherapy and chemotherapy may contribute to improved survival, specifically in patients with good performance status.